Objectives: This study aimed to show whether circulating BMPs levels are associated with phenotype and increased risk of mortality in PAH patients. Methods: Circulating BMPs were measured by ELISA in plasma samples from 10 patients with HPAH and 16 corresponding unaffected relatives with BMPR2 mutations. We also explored the role of BMPs in HPAH (n¼43), unrelated IPAH (n¼113) and normal controls (n¼51). Results: Circulating BMP7 concentrations but BMP2 and BMP4 were greatly increased in the 10 HPAH patients compared with their unaffected relatives. Receiver operating characteristic (ROC) curves indicated that a BMP7 concentration of 13.9 pg/ml could discriminate unaffected mutation carriers from affected mutation carriers with 70.0% sensitivity and 93.8% specificity. HPAH patients had significantly higher BMP7 concentrations than IPAH patients and controls (20.1 (2.8-95.5) vs. 6.5 (0.6-41.3) and 2.5 (0.1-31.8) pg/ml, respectively; P <0.001). Elevated plasma BMP7 concentrations were associated with a higher risk of mortality after adjustment for age, sex, 6-minute walk distance, mean pulmonary arterial pressure, pulmonary vascular resistance, and cardiac output (HR¼2.674, 95% CI 1.152-6.211; P ¼0.022). Conclusions: Elevated circulating BMP7 may reflect disfunction of pulmonary vasculature and serve as a specific biomarker of disease progress in patients with PAH.
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Interaction of HSF1 and Smad3 inhibits cardiac fibrosis and maladaptive hypertrophy induced by pressure overload Objectives: Heat shock transcription factor 1 (HSF1) plays an important role in the pressure overload-induced cardiac hypertrophy and fibrosis. However, the mechanism remains undetermined. The purpose of the present study is to identify the effect of HSF1 on cardiac fibrosis and maladaptive hypertrophy led by pressure overload and the underlying mechanisms. Methods: Expression of P-HSF1 was detected by Western-Blot in human failing heart samples and control samples collected from the left ventricles of dilated cardiomyopathy patients undergoing heart transplants and normal heart donors of traffic accident victims, respectively. Wild type, HSF1 TG and HSF1 -/-mice were imposed with transverse aortic constriction (TAC) or sham operation for 4 weeks and then subjected to echocardiography and invasive hemodynamic measurement. Myocardial fibrosis area (MFA) and perivascular fibrosis area (PVF) were calculated through pathological analysis. Neonatal mouse cardiomyocytes were cultured and mechanically stretched after treatment with KNK437 (specific inhibitors of HSF1) and SIS3 (specific inhibitors of Smad3). Total RNA was prepared from heart tissues of human hearts, mice or cultured neonatal cardiomyocytes and then used for the realtime-PCR. Total protein and nuclear protein were extracted for the co-immunoprecipitation investigating the binding of HSF1 and Smad3.
Results: Transverse aortic constriction (TAC) for 4 weeks induced severer cardiac chamber dilation, dysfunction, interstitial and perivascular fibrosis as well as the reprogramming of fetal genes and over-expression of profibrotic genes in HSF1 -/-mice than in both HSF1 transgenic (TG) and wild type (WT) mice. Furthermore, absence of HSF1 enhanced activation of Smad3. In contrast, over-expression of HSF1 dramatically inhibited TAC induced-activation of TGF-b and its downstream signaling. In vitro, mechanical stretch induced reprogramming of fetal genes and enhanced expression of profibrotic genes and activation of HSF1 (P-HSF1), which were all facilitated by KNK437 (HSF1 inhibitor) but restrained by S1S3 (Smad3 inhibitor). The phosphorylation of Smad3 was more significant in HSF1 -/-mice than those in HSF1 TG mice after 4 weeks' TAC. Physical binding of HSF1 and Smad3 was remarkable in WT mice at 2 nd week but less at 4 th week after TAC, which was increasingly raised in HSF1 TG mice after TAC. Mechanical stretch also increased binding of HSF1 to Smad3 in cardiomyocytes, which can be blocked by either KNK437 or SIS3. Conclusions: The interaction of HSF1 and Smad3 restrains the phosphorylation of Smad3 and then attenuates the TGFb/Smad3 pathway mediated-cardiac fibrosis as well as cardiac maladaptive hypertrophy led by pressure overload.
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Tachycardia pacing induces myocardial neovascularization and mobilizes circulating endothelial progenitor cells partly via SDF-1 pathway in canine M. A. I. Jingting, YangXin Chen, Qiong Qiu, WoLiang Yuan, JingFeng Wang Sun Yat-sen Memorial Hospital of Sun Yat-sen University Objectives: To determine the status of neovascularization in non-ischemic cardiomyopathy induced by chronic rapid ventricular pacing. Methods: Heart failure was induced by chronic rapid right ventricular pacing at 200 beats/min respectively for 3 weeks and 6 weeks in 12 dogs. Sham-operation was performed in another 6 dogs as control. Pan-microvessel density (MVD) was assessed by CD31 and neovascularization density was assessed by CD105. Results: Three-week tachycardia pacing could induce mild/moderate heart failure and 6-week pacing could induce severe heart failure. Mean CD31-MVD and CD105-MVD were significantly increased after 3-week pacing. However, CD105-MVD was significantly decreased by 80% in 6-week pacing group compared with 3-week pacing group, whereas CD31-MVD was only decreased slightly (10%; P<0.05). Myocardial proangiogenic factors stromal cell-derived factor 1 (SDF-1), hypoxia-inducible factors 1a (HIF-1a, a transcription factor which could regulate SDF-1 expression), serum SDF-1 levels and circulating EPCs mobilization greatly elevated after 3 weeks pacing but nearly returned to baseline level after 6 weeks pacing, which were in accordance with the changes of neovascularization levels assessed by CD105. Angiogenesis and migrating ability of EPCs were enhanced after stimulation of SDF-1, which could be abolished by pretreatment with SDF-1 receptor antagonist AMD3100. In addition, angiogenesis and migrating functions of EPCs were significantly enhanced by the serum from 3-week pacing dogs, but had much weaker response to the serum from 6-week pacing dogs. Conclusions: Tachycardia pacing induced non-ischemic heart failure, promoted myocardial neovascularization and mobilized circulating EPCs, which might be mediated partly through SDF-1 pathway.
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BS-KS tablet improves LPA-stimulated endothelial hyperpermeability via RhoA/ROCK pathway L. I. Nannan Objectives: Endothelial hyperpermeability is a significant problem in many cardiovascular disorders, including vascular inflammation, ischemia-reperfusion injury, thrombosis and atherosclerosis. BuShen-KangShuai (BS-KS) tablet, traditional Chinese medicines, has been used for many years in China to treat cardiovascular disease. Our previous experiments have revealed that BS-KS could anti-lipid peroxidation injury, protect endothelial cell funtion, stabilize Atherosclerotic plaque, and prevent the development of Atherosclerotic. While the mechanisms remain elusive. This study examined whether BS-KS exerted anti-hyperpermeability effect in EA.hy296 cells through the RhoA/ROCK pathway. Methods: Transwell chamber model was used to study the permeability changes of endothelial cells and it was quantified by assessing leakage of FITC-dextran. FITCPhalloidin immunofluorescence staining was employed to observe morphological changes in the distribution of F-actin. And the determination of expression of proteins associated RhoA/ROCK pathway was dependent on Western Blot and Q-PCR methods.
Results: The level of endothelial cell (EA.hy926) permeability was increased in LPA treated group. While compared with the model group, BS-KS treatment significantly attenuated effctcs of LPA on cells' hyperpermeability responses (P <0.05). Immunofluorescence showed that treatment of cells reduced stress fiber formation. At the same time, RhoA activity was inhibited, and P-MLC and ROCK2 expression was significantly downregulated both mRNA and protein levels (P <0.05 or P <0.01.). Conclusions: BS-KS has a role in protecting endothelial cells and inhibiting LPAinduced endothelial hyperpermeability response. Which may be achieved by
